Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices

Australia Ophthalmic Devices Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   July 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   105
ISBN Number   not applicable
Product Code   GMD1058
Ask a question about this product?

Price £1,005.00

approximately: $1,499 | €1,197

Summary


Australia Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Australia ophthalmic devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices in Australia

Scope

  • The report provides ophthalmic devices information broken down into detailed categories and segments in Australia.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the ophthalmic devices market in Australia.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Ophthalmic Devices
    • 3.2 Cataract Surgery
      • 3.2.1 Phacoemulsification Equipment
      • 3.2.2 Intra Ocular Lens
    • 3.3 Vision Care
      • 3.3.1 Ophthalmoscopes
      • 3.3.2 Contact lenses
      • 3.3.3 Lens care
      • 3.3.4 Ophthalmic lens
      • 3.3.5 Rigid Gas Permeable Contact Lenses
    • 3.4 Refractive Surgery
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Registration and Conformity Assessment
    • 5.2 Advertising
    • 5.3 Labeling and Packaging
    • 5.4 Post-market Surveillance
    • 5.5 Registration Fee
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 Australia Medical Equipment Cross Market Comparison
  • 9 Ophthalmic Devices Cross Country Comparison
  • 10 Ophthalmic Devices in Australia
    • 10.1 Ophthalmic Devices Overall Revenues by Category (2000-2012)
    • 10.2 Ophthalmic Devices Overall Volume by Category (2000-2012)
    • 10.3 Ophthalmic Devices Overall Company Share (2006-2007)
  • 11 Vision Care in Australia
    • 11.1 Vision Care Revenues by Segment (2000-2012)
    • 11.2 Vision Care Volume by Segment (2000-2012)
    • 11.3 Vision Care Average Price (2000-2012)
    • 11.4 Vision Care Distribution Share (2006-2007)
    • 11.5 Vision Care Company Share (2006-2007)
  • 12 Cataract Surgery in Australia
    • 12.1 Cataract Surgery Revenues by Segment (2000-2012)
    • 12.2 Cataract Surgery Volume by Segment (2000-2012)
    • 12.3 Cataract Surgery Average Price (2000-2012)
    • 12.4 Cataract Surgery Distribution Share (2006-2007)
    • 12.5 Cataract Surgery Company Share (2006-2007)
  • 13 Refractive Surgery in Australia
    • 13.1 Refractive Surgery Revenues (2000-2012)
    • 13.2 Refractive Surgery Volume by Segment (2000-2012)
    • 13.3 Refractive Surgery Average Price (2000-2012)
    • 13.4 Refractive Surgery Distribution Share (2006-2007)
    • 13.5 Refractive Surgery Company Share (2006-2007)
  • 14 Advanced Ocular Systems Limited Company Profile
    • 14.1 Company Overview
    • 14.2 Advanced Ocular Systems Limited Pipeline Products
      • 14.2.1 Advanced Ocular Systems Limited Pipeline Products by Equipment Type
      • 14.2.2 Advanced Ocular Systems Limited Pipeline Products by Development Stage
      • 14.2.3 Advanced Ocular Systems Limited Pipeline Products by Therapy Area
  • 15 Alcon, Inc. Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
      • 15.2.2 Product Development
      • 15.2.3 Sales and Marketing
    • 15.3 Alcon, Inc. Pipeline Products
      • 15.3.1 Alcon, Inc. Pipeline Products by Equipment Type
      • 15.3.2 Alcon, Inc. Pipeline Products by Development Stage
      • 15.3.3 Alcon, Inc. Pipeline Products by Therapy Area
      • 15.3.4 Alcon, Inc. Pipeline Products by Clinical Trials
  • 16 Austvet Pty. Ltd. Company Review
    • 16.1 Company Overview
  • 17 Bausch & Lomb Incorporated Company Profile
    • 17.1 Company Overview
    • 17.2 Value Chain Analysis
      • 17.2.1 Manufacturing
      • 17.2.2 Product Development
      • 17.2.3 Sales and Marketing
    • 17.3 Bausch & Lomb Incorporated Pipeline Products
      • 17.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type
      • 17.3.2 Bausch & Lomb Incorporated Pipeline Products by Development Stage
      • 17.3.3 Bausch & Lomb Incorporated Pipeline Products by Therapy Area
      • 17.3.4 Bausch & Lomb Incorporated Pipeline Products by Clinical Trials
      • 17.3.5 Bausch & Lomb Incorporated Pipeline Products by News Summary
  • 18 BOC Ophthalmic Instruments Company Review
    • 18.1 Company Overview
  • 19 CIBA Vision Corporation Company Profile
    • 19.1 Company Overview
    • 19.2 CIBA Vision Corporation Pipeline Products
      • 19.2.1 CIBA Vision Corporation Pipeline Products by Equipment Type
      • 19.2.2 CIBA Vision Corporation Pipeline Products by Development Stage
      • 19.2.3 CIBA Vision Corporation Pipeline Products by Therapy Area
      • 19.2.4 CIBA Vision Corporation Pipeline Products by Clinical Trials
  • 20 CustomVis Plc Company Profile
    • 20.1 Company Overview
    • 20.2 CustomVis Plc Pipeline Products
      • 20.2.1 CustomVis Plc Pipeline Products by Equipment Type
      • 20.2.2 CustomVis Plc Pipeline Products by Development Stage
      • 20.2.3 CustomVis Plc Pipeline Products by Clinical Trials
  • 21 Designs For Vision Pty Ltd Company Review
    • 21.1 Company Overview
  • 22 Ellex Medical Lasers Limited Company Profile
    • 22.1 Company Overview
    • 22.2 Ellex Medical Lasers Limited Pipeline Products
      • 22.2.1 Ellex Medical Lasers Limited Pipeline Products by Equipment Type
      • 22.2.2 Ellex Medical Lasers Limited Pipeline Products by Development Stage
      • 22.2.3 Ellex Medical Lasers Limited Pipeline Products by Therapy Area
  • 23 Essilor International Company Profile
    • 23.1 Company Overview
    • 23.2 Value Chain Analysis
      • 23.2.1 Manufacturing
      • 23.2.2 Product Development
      • 23.2.3 Sales and Marketing
  • 24 Johnson & Johnson Vision Care, Inc. Company Profile
    • 24.1 Company Overview
  • 25 Financial Deals Landscape
    • 25.1 Acquisition
      • 25.1.1 Luxottica Group Acquires OPSM Group
  • 26 Recent Developments
    • 26.1 Strategy and Business Planning
      • 26.1.1 Jun 16, 2008: AMO Announces Collaboration With IER
  • 27 Appendix
    • 27.1 Global Markets Direct Research Methodology
    • 27.2 Coverage
    • 27.3 Secondary Research
    • 27.4 Primary Research
    • 27.5 Models
    • 27.6 Forecasts
    • 27.7 Expert Panels
    • 27.8 Currency Conversion
    • 27.9 Contact Us
    • 27.10 Disclaimer
    • 1.1 List of Tables
    • Table 1: Healthcare Infrastructure in Australia, 2005
    • Table 2: Healthcare Personnel in Australia, 2005
    • Table 3: Hospital Wards by Specialty in Australia, 2003-2007
    • Table 4: Doctors by Specialty in Australia, 2003-2007
    • Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007
    • Table 6: Fee for Registered Device in Australia, 2007
    • Table 7: Fee for Device Clinical Trial in Australia, 2007
    • Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007
    • Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007
    • Table 10: Fee for Registration of Listed Devices in Australia, 2007
    • Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007
    • Table 12: Fee for Registration of Included Devices in Australia, 2007
    • Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007
    • Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007
    • Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007
    • Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007
    • Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007
    • Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007
    • Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007
    • Table 22: Australia, Medical Equipment Market Comparison
    • Table 23: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012
    • Table 24: Ophthalmic Devices, Australia, Category Revenues ($ mn), 2000-2012
    • Table 25: Ophthalmic Devices Market, Australia, Portfolio Analysis
    • Table 26: Ophthalmic Devices, Australia, Category Revenues ($ mn), Historic, 2000-2007
    • Table 27: Ophthalmic Devices, Australia, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 28: Ophthalmic Devices, Australia, Category Volume (Units), 2000-2012
    • Table 29: Ophthalmic Devices, Australia, Category Volume (Units), Historic, 2000-2007
    • Table 30: Ophthalmic Devices, Australia, Category Volume (Units), Forecast, 2007-2012
    • Table 31: Ophthalmic Devices, Australia, Overall Company Share by Revenue, 2006-2007
    • Table 32: Vision Care, Australia, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 33: Vision Care, Australia, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 34: Vision Care, Australia, Volume (Units) by Segment, Historic, 2000-2007
    • Table 35: Vision Care, Australia, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 36: Vision Care, Australia, Average Price ($), Historic, 2000-2007
    • Table 37: Vision Care, Australia, Average Price ($), Forecast, 2007-20012
    • Table 38: Vision Care, Australia, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 39: Vision Care, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 40: Cataract Surgery, Australia, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 41: Cataract Surgery, Australia, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 42: Cataract Surgery, Australia, Volume (Units) by Segment, Historic, 2000-2007
    • Table 43: Cataract Surgery, Australia, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 44: Cataract Surgery, Australia, Average Price ($), Historic, 2000-2007
    • Table 45: Cataract Surgery, Australia, Average Price ($), Forecast, 2007-2012
    • Table 46: Cataract Surgery, Australia, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 47: Cataract Surgery, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 48: Refractive Surgery, Australia, Revenues ($ mn), Historic, 2000-2007
    • Table 49: Refractive Surgery, Australia, Revenues ($ mn), Forecast, 2007-2012
    • Table 50: Refractive Surgery, Australia, Volume (Units), Historic, 2000-2007
    • Table 51: Refractive Surgery, Australia, Volume (Units), Forecast, 2007-2012
    • Table 52: Refractive Surgery, Australia, Average Price ($), Historic, 2000-2007
    • Table 53: Refractive Surgery, Australia, Average Price ($), Forecast, 2007-2012
    • Table 54: Refractive Surgery, Australia, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 55: Refractive Surgery, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 56: Advanced Ocular Systems Limited Pipeline Products by Equipment Type
    • Table 57: Advanced Ocular Systems Limited Pipeline Products By Development Stage
    • Table 58: Advanced Ocular Systems Limited Pipeline Products By Therapy Area
    • Table 59: Alcon, Inc. Pipeline Products by Equipment Type
    • Table 60: Alcon, Inc. Pipeline Products By Development Stage
    • Table 61: Alcon, Inc. Pipeline Products By Therapy Area
    • Table 62: Alcon, Inc. Pipeline Products By Clinical Trials
    • Table 63: Bausch & Lomb Incorporated Pipeline Products by Equipment Type
    • Table 64: Bausch & Lomb Incorporated Pipeline Products By Development Stage
    • Table 65: Bausch & Lomb Incorporated Pipeline Products By Therapy Area
    • Table 66: Bausch & Lomb Incorporated Pipeline Products By Clinical Trials
    • Table 67: Bausch & Lomb Incorporated Pipeline Products By News Summaries
    • Table 68: CIBA Vision Corporation Pipeline Products by Equipment Type
    • Table 69: CIBA Vision Corporation Pipeline Products By Development Stage
    • Table 70: CIBA Vision Corporation Pipeline Products By Therapy Area
    • Table 71: CIBA Vision Corporation Pipeline Products By Clinical Trials
    • Table 72: CustomVis Plc Pipeline Products by Equipment Type
    • Table 73: CustomVis Plc Pipeline Products By Development Stage
    • Table 74: CustomVis Plc Pipeline Products By Clinical Trials
    • Table 75: Ellex Medical Lasers Limited Pipeline Products by Equipment Type
    • Table 76: Ellex Medical Lasers Limited Pipeline Products By Development Stage
    • Table 77: Ellex Medical Lasers Limited Pipeline Products By Therapy Area
    • Table 78: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005
    • Figure 2: Healthcare Financing Framework in Australia, 2007
    • Figure 3: Healthcare System in Australia, 2007
    • Figure 4: Classification of Medical Devices in Australia, 2007
    • Figure 5: Classification of Noninvasive Devices in Australia, 2007
    • Figure 6: Classification of Invasive Devices in Australia, 2007
    • Figure 7: Classification of Invasive Devices in Australia, 2007
    • Figure 8: Classification of Active Devices in Australia, 2007
    • Figure 9: Classification of Special Medical Devices in Australia, 2007
    • Figure 10: Conformity Assessment Procedure for Medical Devices in Australia, 2007
    • Figure 11: Australia, Medical Equipment Market Comparison, 2007
    • Figure 12: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012
    • Figure 13: Ophthalmic Devices Market, Country Comparison
    • Figure 14: Ophthalmic Devices, Australia, Category Revenues ($ mn), 2000-2012
    • Figure 15: Ophthalmic Devices Market, Australia, Portfolio Analysis
    • Figure 16: Ophthalmic Devices, Australia, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 17: Ophthalmic Devices, Australia, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 18: Ophthalmic Devices, Australia, Overall Company Share (%), 2007
    • Figure 19: Vision Care, Australia, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 20: Vision Care, Australia, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 21: Vision Care, Australia, Company Share (%), 2007
    • Figure 22: Cataract Surgery, Australia, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 23: Cataract Surgery, Australia, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 24: Cataract Surgery, Australia, Company Share (%), 2007
    • Figure 25: Refractive Surgery, Australia, Revenues ($ mn), Historic, 2000-2007
    • Figure 26: Refractive Surgery, Australia, Revenues ($ mn), Forecast, 2007-2012
    • Figure 27: Refractive Surgery, Australia, Volume (Units), Historic, 2000-2007
    • Figure 28: Refractive Surgery, Australia, Volume (Units), Forecast, 2007-2012
    • Figure 29: Refractive Surgery, Australia, Company Share (%), 2007
    • Figure 30: Advanced Ocular Systems Limited Pipeline Products By Development Stage
    • Figure 31: Alcon, Inc., Value Chain Analysis
    • Figure 32: Bausch & Lomb Incorporated, Value Chain Analysis
    • Figure 33: CustomVis Plc Pipeline Products By Development Stage
    • Figure 34: Ellex Medical Lasers Limited Pipeline Products By Development Stage
    • Figure 35: Essilor International, Value Chain Analysis
    • Figure 36: Global Markets Direct Methodology